Citi analyst Filippo Falorni lowered the firm’s price target on Keurig Dr Pepper (KDP) to $32 from $37 and keeps a Buy rating on the shares. The firm adjusted targets in the beverages, household and personal care group as part of a Q1 preview. Investor focus will be on the sector’s margin risk amid higher oil prices and many commodities, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper price target lowered to $28 from $32 at Barclays
- Keurig Dr Pepper price target lowered to $35 from $38 at BofA
- Keurig Dr Pepper price target lowered to $37 from $40 at Wells Fargo
- Keurig Dr Pepper price target lowered to $32 from $36 at UBS
- Keurig Dr Pepper resumed with an In Line at Evercore ISI